Le Lézard
Classified in: Covid-19 virus
Subjects: PDT, MAT

CannabCo Reveals 41% Odourless Cannabistm Dry Flower Strain.

CannabCo set to capture market with high THC Odourless Cannabistm Products

BRAMPTON, ON, Nov. 30, 2021 /CNW/ - CannabCo Pharmaceutical Corp. (CannabCo), a Canadian company located in Brampton, Ontario, is pleased to announce a milestone achievement with the testing of one of the industry's most potent cannabis strains at 41% total quantifiable cannabinoid content.  The strain features a lab tested cannabinoid count of 40.59% with a THC rating of 35%.  The main distinguishing feature of the strain, other than its high THC content, is that it was created with Purecanntm, CannabCo's proprietary Odourless Cannabistm technology. 

Certificate of analysis for 41% Purecanntm strain. (CNW Group/CannabCo Pharmaceutical Corp.)

The deployment of Purecanntm makes the product virtually odourless when smoked or stored allowing for a reduced impact on others sensitive to the pungent odour of cannabis.  This is an industry first and a product the company claims is sorely needed in the marketplace. 

The company has developed and tested multiple Purecanntm strains ranging from under .3% for the smoke-able hemp market, with numerous strains in the 20-32% range, culminating to the highest THC range currently at 35%.

Currently the highest THC dry flower in the Ontario Cannabis Store lists at a maximum of 32% THC.  Mark Pellicane, CannabCo's CEO, thinks they can do better.  "We are always pushing the limits with our technologies" said Pellicane, "With the demand for high THC strains, it made sense to target the same in odourless variants and our result is one of the highest THC strains produced to date".  Pellicane also stated that the company has multiple strains in the high 30's in the works, as well as market specific strains with targeted THC levels and cannabinoid profiles for specific markets and effects.

 "We've taken the time during the COVID-19 pandemic to developed products suitable for multiple target markets" said Mark Novak, the company's COO.  "For example, Israel currently has a THC cap on dry bud, so we've developed products specific to the 20-25% range in order to maximize consumer uptake for that specific medical and pending recreational markets". The company has been approached for Purecanntm deployment in multiple markets such as the USA, EU, Israel, Australia, and South America. 

The company intends to continue to develop innovative and first to market products, with its undisclosed technology and grow partner.  CannabCo maintains full ownership and rights to Purecanntm and the odourless cannabistm technology.

About CannabCo Pharmaceutical Corp.

CannabCo Pharmaceutical Corp. is a Canadian based full service cannabis company with operations in Brampton, Ontario.  The company has received its "Confirmation of Readiness" from Health Canada to become a licensed producer and is currently building out its pilot facility in the Brampton Area.  The company currently has two primary technologies, Purecanntm for the growing of Odourless Cannabistm, and  PHOENIX, and enhanced cultivation system featuring a hydroponic grow system with high productivity and significantly lower cost per gram than traditional grows.

Forward Looking Statements

This press release may contain certain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements may be identified by  statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts" and other similar expressions. Actual results and developments may differ materially from those contemplated by these statements. Although CannabCo believes that the expectations reflected in forward-looking statements in this press release are reasonable, there can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements in this press release.  Comments and claims related to PHOENIX and PURECANN are based solely on that observed and the opinions of management as well as third party verifications provided to CannabCo from industry experts.

SOURCE CannabCo Pharmaceutical Corp.

These press releases may also interest you

at 20:50
Enviva Inc. ("Enviva," "we," "us," or "our") today announced that it has priced an underwritten public offering (the "Offering") of 4,300,000 common shares at $70.00 per share. Enviva has granted the underwriters a 30-day option to purchase up to an...

at 20:45
Online On-demand Home Services Market in Malaysia Facts at a Glance- Total Pages: 120 Companies: 10+ ? ADVANCE DREAMS VENTURE Sdn...

at 20:30
According to the research report "Online On-demand Home Services Market in Southeast Asia - Forecast and Analysis Report 2021-2025", the market will witness a YOY growth of 41.92% in 2021, at a CAGR of 54% during the forecast period. The report is...

at 20:15
There has been a constant rise in the demand for product premiumization in toys market which is influenced by the expansion of the product portfolio, as per the latest research report of "Toys Market in Europe - Forecast and Analysis"....

at 20:05
WiSA, LLC, a wholly-owned subsidiary of Summit Wireless Technologies, Inc. , a leading provider of immersive, wireless sound technology for smart devices, will integrate WiSA's multichannel spatial audio capabilities into Realtek's 5GHz IoT chip...

at 20:00
Road Freight Transportation Market Facts at a Glance- Total Pages: 120 Companies: 10+ ? Including DACHSER SE, Deutsche Post DHL...

News published on 30 november 2021 at 07:43 and distributed by: